Combined vitamin B6-magnesium treatment in autism spectrum disorder (Q24245359)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Combined vitamin B6-magnesium treatment in autism spectrum disorder (English)

0 references

main subject

autism spectrum disorder

0 references

0 references

0 references

0 references

0 references

0 references

Chad Nye

1

0 references

Alejandro Brice

series ordinal

2

0 references

language of work or name

English

0 references

publication date

19 October 2005

0 references

published in

0 references

page(s)

CD003497

0 references

issue

4

0 references

cites work

High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Pyridoxine treatment in a subgroup of children with pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Effects of pyridoxine and magnesium on autistic symptoms--initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Brief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

The effect of high doses of vitamin B6 on autistic children: a double- blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Pyridoxine and Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Domains of the Childhood Autism Rating Scale: relevance for diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

The epidemiology of autism: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

21 January 2018

The prevalence of autism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Normative data on revised Conners Parent and Teacher Rating Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Behavioral assessment of psychopathology in children: infantile autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003497.PUB2

Modifications in urinary homovanillic acid after ingestion of vitamin B6; functional study in autistic children (author's transl)

21 January 2018

1 reference

12 December 2020

[Clinical and biochemical value of Magnesium + vitamin B6 combination in the treatment of residual autism in adults]

1 reference

12 December 2020

Effects of vitamin B6 on averaged evoked potentials in infantile autism.

1 reference

12 December 2020

A scale for rating symptoms of patients with the syndrome of autism in real life settings.

1 reference

12 December 2020

[Experiences with pyrithioxin in brain-damaged children with autistic syndrome]

1 reference

12 December 2020

[Clinical (behavior scale items), electrophysiologic (conditioned evoked potentials) and biochemical (urinary homovanillic acid) markers in infantile autism]

1 reference

12 December 2020

Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children

1 reference

12 December 2020

Behavioral and cognitive measures used in psychopharmacological studies of infantile autism.

1 reference

12 December 2020

[Value of behavior scales and urinary homovanillic acid determinations in monitoring the combined treatment with vitamin B6 and magnesium of children displaying autistic behavior]

1 reference

12 December 2020

Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics

1 reference

12 December 2020

[Biological and clinical effects of oral magnesium and associated magnesium-vitamin B6 administration on certain disorders observed in infantile autism (author's transl)]

1 reference

12 December 2020

Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour.

1 reference

12 December 2020

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

12 December 2020

An evaluation of niacinamide in the treatment of childhood schizophrenia

1 reference

12 December 2020